Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
American Journal of Therapeutics|June 1, 1995
Lack of Pharmacokinetic Interaction between Aspirin and WarfarinWilliam D. Fiske, Jill M. Connell, Irma H. BenedekDrug Design, Development and Therapy|December 14, 2011
Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended releaseIrma H Benedek, Janet Jobes, Qinfang Xiang, et al.International Journal of Obesity|January 1, 1986
Renal function in the obese Zucker ratW D Fiske, R A Blouin, B Mitchell, et al.Journal of Dairy Science|November 13, 2018
Technical note: Development of a noninvasive respiration rate sensor for cattleS Strutzke, D Fiske, G Hoffmann, et al.The Journal of Pain|January 3, 2012
The effects of ethanol on the bioavailability of oxymorphone extended-release tablets and oxymorphone crush-resistant extended-release tabletsWilliam D Fiske, Janet Jobes, Qinfang Xiang, et al.Clinical Pharmacology and Therapeutics|April 29, 1998
Pharmacodynamics and pharmacokinetics of DMP 728, a platelet GPIIb/IIIa antagonist, in healthy subjectsW Michaelis, P Turlapaty, J Gray, et al.International Journal of Clinical Pharmacology and Therapeutics|April 18, 2003
Population pharmacokinetic meta-analysis with efavirenzJ S Barrett, A S Joshi, M Chai, et al.Pharmaceutical Development and Technology|August 23, 2008
Identification and control of a degradation product in Avapro film-coated tablet: low dose formulationGeorge Wang, John D Fiske, Scott P Jennings, et al.AAPS Pharmscitech|June 8, 2011
Investigation into stability of poly(vinyl alcohol)-based Opadry® II filmsOtilia M Y Koo, John D Fiske, Haitao Yang, et al.British Journal of Clinical Pharmacology|December 1, 1983
Serum alpha 1-acid glycoprotein and the binding of drugs in obesityI H Benedek, W D Fiske, W O Griffen, et al.Pageof 3